CardioNet, headquartered in Pennsylvania, became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet Mobile Cardiac Outpatient TelemetryTM (MCOTTM) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients–at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.
Recent NewsMore >>
DateTitle 
06/10/13CardioNet, Inc. Enters Into Agreement with UnitedHealthcare Insurance Company
Provides Coverage for CardioNet MCOTTM CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Jun. 10, 2013-- CardioNet, Inc. (NASDAQ:BEAT) (“CardioNet”), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today that the Company has entered into a three-year National Provider Agreement with UnitedHealthcare Insurance Company, covering all of CardioNet’s monitoring modalities, including Mobile Cardi... 
Printer Friendly Version
04/22/13CardioNet, Inc. Reports First Quarter 2013 Financial Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Apr. 22, 2013-- CardioNet, Inc. (NASDAQ:BEAT), the leading wireless medical technology and research services company focused on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the first quarter ended March 31, 2013. First Quarter 2013 Highlights Revenue of $32.4 million and positive adjusted EBITDA of $2.4 million for the first quarter 2013 ... 
Printer Friendly Version
04/22/13CardioNet, Inc. to Modify Business Structure in Support of Growth Strategy
Company to Change Name to BioTelemetry, Inc. CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Apr. 22, 2013-- CardioNet, Inc. (“CardioNet” or the “Company”) (NASDAQ:BEAT), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today that its Board of Directors has approved a plan to adopt a holding company structure to more effectively facilitate its ongoing growth plan. Reflecting the change in ... 
Printer Friendly Version
04/22/13CardioNet, Inc. Reschedules Q1 Earnings Results and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Apr. 22, 2013-- CardioNet, Inc. (NASDAQ:BEAT) will release its first quarter 2013 earnings on Monday, April 22, 2013 at 4:30 PM Eastern Time. The CardioNet quarterly conference call will be held at 8:00 AM Eastern Time, Tuesday, April 23, 2013. The broadcast will be available through the investor information section of the CardioNet web page at www.cardionet.com. If you are unable to participate during the live... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


STOCK QUOTE
BEAT (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$6.11
Change (%) Stock is Up 0.34 (5.89%)
Volume2,357,505
Data as of 06/17/13
4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

EMAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © CardioNet 2002-2009, All Rights Reservedprivacy policy/termssite mapinfo@cardionet.com